{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" and the context provided seems to be about estimating infections and the impact of non-lockdown measures. Wait, the titles and passages are a bit confusing. Let me look again.\n\nThe context has four entries. The first three are just the title \"Estimating the number of infections and the impact of non-\" followed by \"Passage: Lockdown\". The fourth one is \"Title: Estimating the number of infections and the impact of non- Passage: banned Implemented with lockdown.57 24/3/2020\". Hmm, maybe there's a formatting issue here. The titles are cut off, but the key part is \"non-lockdown\" and \"banned Implemented with lockdown.57 24/3/2020\".\n\nSo, the user is asking for a definition of a lockdown. The context seems to be about studies or reports on the effects of lockdowns versus non-lockdown measures. The mention of \"banned Implemented with lockdown.57 24/3/2020\" might refer to a specific implementation date or a study from March 24, 2020. \n\nA lockdown typically refers to strict measures imposed by authorities to restrict movement and gatherings to control the spread of a disease, like during a pandemic. The context here is likely discussing how lockdowns affect infection rates compared to not having them. Since the user's question is straightforward, the answer should define a lockdown in general terms, possibly mentioning its purpose and context in public health, especially during a pandemic. The provided context might be from a study that looked into the effectiveness of lockdowns, so the answer should be concise but accurate based on common knowledge, as the context isn't very detailed.\n</think>\n\nA **lockdown** is a public health measure implemented by authorities to restrict movement and gatherings of people in order to slow the spread of a contagious disease, such as during a pandemic. It typically involves closing non-essential businesses, schools, and public spaces, and limiting travel to essential activities only. The goal is to reduce person-to-person transmission and prevent healthcare systems from becoming overwhelmed. The context provided suggests studies analyzing the impact of lockdowns versus non-lockdown policies on infection rates.",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which I know stands for Chikungunya virus. I need to look through the provided context to find all the mentioned complications.\n\nFirst, the context mentions that children are disproportionately affected by severe CHIKV. Then, there's a list of complications from most common to least common. Let me check that part again. The passage says: \"Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.\" So that's a list of seven complications. \n\nAdditionally, there's information about transmission from mothers to neonates during the perinatal period. The study by Ramful et al. mentions that neonates developed meningoencephalitis. Another study by Gerardin et al. reports neonatal infections leading to encephalitis due to vertical transmission. Also, there's mention of a high degree of morbidity in neonates, with all being symptomatic by Day 4. \n\nWait, the user is asking for complications associated with CHIKV in general. The main list includes respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other CNS problems, and kidney failure. Then, specific complications in neonates like encephalitis from vertical transmission. Also, the context notes that severe cases in adults over 65 and those with underlying conditions can lead to death (over 33% mortality). But the question is about complications, not mortality rates. \n\nSo I should list all the complications mentioned. The primary list from the first passage includes seven complications. Then, neonatal complications include meningoencephalitis and encephalitis. Also, fetal deaths were reported in some cases. Should I include fetal deaths as a complication? The context says \"only three fetal deaths were reported\" during the La Reunion epidemic when mothers were infected long before delivery. That might be a separate complication related to pregnancy. \n\nSo compiling all the complications: respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, kidney failure, encephalitis (specifically in neonates from vertical transmission), and fetal",
      "retrieved_chunks": [
        "The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure . Title: Chikungunya: A Potentially Emerging Epidemic? Passage: and complications. Title: Chikungunya: A Potentially Emerging Epidemic?",
        "Title: Chikungunya: A Potentially Emerging Epidemic? Passage: More than 50% of patients who suffer from severe CHIKF are over 65 y old, and more than 33% of them die. Most adults who suffer from severe CHIKF have underlying medical conditions . The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure .",
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis. Of those mothers who, during the La Reunion Island epidemic, were infected long before delivery, only three fetal deaths were reported . Ramful et al.",
        "Passage: and complications. Title: Chikungunya: A Potentially Emerging Epidemic? Passage: During the 2005-2006 La Reunion Island outbreaks, Ramful et al. discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms.",
        "Title: Chikungunya: A Potentially Emerging Epidemic? Passage: A similar study by Gerardin et al. reported nineteen cases of neonatal infection associated with intrapartum maternal viremia that progressed to develop encephalitis owing to vertical transmission from infected mothers ."
      ],
      "computed_relevance": 0.34782608695652173,
      "computed_utilization": 0.34782608695652173,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's try to figure out what Clade A contains based on the provided context. The user is asking about \"Clade A,\" but looking through the passages, I notice mentions of clades like 1A.1, 1B.1, 1C, etc. There's no direct mention of a \"Clade A\" in the passages. Instead, the main lineages discussed are 1A, 1B, and 1C. \n\nThe first passage mentions that each clade had an APD (Average Pairwise Distance) of more than 7% from other clades and less than 7% within the clade. Exceptions are noted for certain clades like 1B.1 and 1B.2. Another passage talks about the 1A lineage being split into three second-order divisions. There's also information about the 1C lineage having viruses from China and South Korea.\n\nSince the question refers to \"Clade A,\" but the context uses numbers and letters like 1A, 1B, 1C, maybe \"Clade A\" is a misinterpretation. The user might be referring to the 1A lineage. The 1A lineage is mentioned as containing 1,889 viruses from 34 countries collected from 2010 to the present. It was divided into three second-order divisions. Also, there were exceptions in the 1A lineage, like the 1A.1 clade and the extensive 1A.1.1 clade.\n\nHowever, the problem is that the question specifically says \"Clade A,\" but the context doesn't mention \"Clade A.\" The closest is 1A, which is a lineage. The answer might be that there's no Clade A, but if the user meant 1A, then the answer would be about the 1A lineage containing viruses from 34 countries, split into three second-order divisions, etc. Alternatively, maybe there's confusion in the naming. Since the user might have a typo or misunderstanding, but based on the given info, I need to check all passages again.\n\nLooking again, all the titles and passages refer to lineages like 1A, 1B, 1C. There's no standalone \"Clade A.\" The answer might be that Clade A isn't mentioned, but perhaps the user intended to ask about",
      "retrieved_chunks": [
        "For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting. The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades.",
        "Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception. Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 . For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade.",
        "Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 . For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade. The one within-clade exception in this lineage was 1C.2 , which had multiple monophyletic\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: The 1B human seasonal lineage within-and between-clade APDs are presented in Table 3 . For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades .",
        "Title: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1A swine lineage. The 1A lineage contained 1,889 viruses from 34 countries collected from 2010 to the present . According to our nomenclature rules, we refined the classification of 1A viruses into three second-order divisions, each of which corresponds to earlier, regional classifica- Table 2 . Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception. Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage.",
        "Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting. The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades. The numerically dominant clades reflected intensive surveillance in the United States , investigator sequencing efforts in Canada , and the rapid dissemination of the 2009 H1N1 pandemic virus across global swine populations . Similarly, coordinated surveillance in Europe and Asia captured two primary clades of 1C Eurasian avian lineage currently circulating in the two continents."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. \n\nFirst, I need to look through the provided context for relevant information. The passages mention the S1 and S2 subunits of the spike glycoprotein. Specifically, there's a part that says the S1 subunit of 2019-nCoV shares around 70% identity with the two bat SARS-like CoVs and human SARS-CoV. Also, it notes that the core domain of the RBD (receptor-binding domain) is highly conserved. However, most amino acid differences in the RBD are in the external subdomain, which interacts directly with the host receptor.\n\nSo, putting this together, the S1 subunit of 2019-nCoV has about 70% similarity to SARS-like CoVs and human SARS-CoV. The core part of the RBD is conserved, but the external part where it binds to the host receptor has differences. This might explain how 2019-nCoV can infect humans but also have some differences in transmission or pathogenesis compared to SARS-CoV. The answer should highlight the 70% identity and the conserved vs. variable regions in the RBD.\n</think>\n\nThe S1 subunit of 2019-nCoV shares **around 70% amino acid identity** with the S1 subunits of bat SARS-like coronaviruses (SARSr-CoVs) and human SARS-CoV. While the **core domain of the receptor-binding domain (RBD)** in the S1 subunit is highly conserved across these viruses, most amino acid differences are localized to the **external subdomain** of the RBD. This external region, responsible for direct interaction with the host receptor, exhibits variability, which may influence receptor usage, interspecies transmission, and pathogenesis. Notably, bat SARSr-CoVs often have deletions in the RBD compared to human SARS-CoV, but 2019-nCoV retains a more intact RBD structure similar to human SARS-CoV.",
      "retrieved_chunks": [
        "The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b. The 2019-nCoV had the same SL6, SL7, and SL8 as SARS-CoV, and an additional",
        "Title: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: Spike glycoprotein comprised of S1 and S2 subunits. The S1 subunit contains a signal peptide, followed by an N-terminal domain and receptor-binding domain , while the S2 subunit contains conserved fusion peptide , heptad repeat 1 and 2, transmembrane domain , and cytoplasmic domain . We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV . Thus the broad spectrum antiviral peptides against S2 would be an important preventive and treatment modality for testing in animal models before clinical trials . Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ).",
        "Thus the broad spectrum antiviral peptides against S2 would be an important preventive and treatment modality for testing in animal models before clinical trials . Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ). Most of the amino acid differences of RBD are located in the external subdomain, which is responsible for the direct interaction with the host receptor. Further investigation of this soluble variable external subdomain region will reveal its receptor usage, interspecies transmission and pathogenesis. Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.",
        "Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus. These findings provide the basis for\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: As shown in Figure 7 , the SARS-CoV 5 \u2032 -UTR contains SL1, SL2, SL3, SL4, S5, SL5A, SL5B, SL5C, SL6, SL7, and SL8. The SL3 contains trans-cis motif . The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV.",
        "Further investigation of this soluble variable external subdomain region will reveal its receptor usage, interspecies transmission and pathogenesis. Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV. But some\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: bat, civet and human SARS coronaviruses. However, the external subdomain of Spike\u2019s receptor binding domain of 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses. Remarkably, its orf3b encodes a completely novel short protein."
      ],
      "computed_relevance": 0.08333333333333333,
      "computed_utilization": 0.125,
      "computed_completeness": 0.5,
      "computed_adherence": 1.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" I need to base my answer on the provided context. Let me go through the passages again to gather relevant information.\n\nFirst, the context mentions that Bacillus species, including B. subtilis, are used in probiotics like Biosubtyl, Biosporin, etc. They're part of traditional fermented foods and have beneficial effects on the gut. The passages also talk about how B. subtilis helps maintain gut barrier integrity, reduces endotoxins, and decreases inflammation. \n\nThere's a part about the secretome of intestinal bacilli, which refers to the proteins they secrete. B. subtilis produces substances like surfactins, fengycins, and iturins. These have antimicrobial and anti-inflammatory properties. Surfactins, even though less abundant, have a broad antimicrobial range and antiviral actions. They also protect against other bacteria's antibiotics and modulate cytokines.\n\nThe context also notes that Bacillus species were once thought to be transient in the gut but recent studies show they colonize there. They're effective in treating intestinal diseases like colitis, diarrhea, and IBS. In animal studies, B. subtilis helped restore gut flora balance by increasing beneficial bacteria and reducing harmful ones.\n\nPutting this together, Bacillus subtilis is a probiotic bacterium that supports gut health through various mechanisms. It's used in probiotics, produces beneficial compounds, and has therapeutic effects on gut-related conditions. I should structure the answer to include its role in probiotics, the substances it produces, its effects on gut health, and its applications in treating diseases.\n</think>\n\n**Answer:**  \n*Bacillus subtilis* is a probiotic bacterium belonging to the *Bacillus* genus, known for its beneficial effects on intestinal health. It is used in probiotic formulations (e.g., Biosubtyl, Biosporin) and traditional fermented foods. Key features include:  \n1. **Gut Health Benefits**: It maintains gut barrier integrity, reduces endotoxins, and decreases inflammation, aiding in the prevention/treatment of conditions like diarrhea, colitis, and irritable bowel syndrome.  \n2. **Secreted Compounds**: Produces bioactive lipopeptides (surfactins, fengycins, iturins) with antimicrobial, antiv",
      "retrieved_chunks": [
        "subtilis also retained gut barrier integrity, decreased the endotoxin concentration and reduced gut inflammation Bene et al., 2017) . Sporulation of B. subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome.",
        "have been isolated from the healthy human GIT, where they are well-adapted and are more colonizing than transient . In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B. subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 . The less abundant surfactins unlike other types of Bacillus lipopeptides exhibit a broad range of antimicrobial activities and possess antiviral action . They protect bacilli against extracellular antibiotic-containing vesicles of other species and inhibit phospholipase A2 resulting in subsequent downregulation of pro-inflammatory cytokines and upregulation of anti-inflammatory cytokines .",
        "as soil microorganisms were considered transient. Recent studies show that they are present in the GIT in the amounts significantly higher than what can be explained by their ingestion with food only. Bacillus spp. have been isolated from the healthy human GIT, where they are well-adapted and are more colonizing than transient . In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B.",
        "Title: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: The efficacy of Lactobacillus and Bacillus in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer was demonstrated . In particular, treatment of colorectal colitis in mice with probiotic B. subtilis restored balance in gut microflora: beneficial species of Bifidobacterium, Lactobacillus, and Butyricicoccus spp. were increased, while gut damage-promoting species of Acinetobacter sp., Ruminococcus sp., Clostridium spp., and Veillonella sp. were decreased .",
        "In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp. as soil microorganisms were considered transient. Recent studies show that they are present in the GIT in the amounts significantly higher than what can be explained by their ingestion with food only."
      ],
      "computed_relevance": 0.32,
      "computed_utilization": 0.32,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. First, I need to look through the provided contexts to find any mentions of such research.\n\nLooking at the first context, it talks about the 1889 pandemic having three major waves, with the 1892 wave being the most intense. It also mentions the 1918 pandemic's herald waves possibly starting in 1915. However, this seems to be about multi-wave pandemics, not single-wave. So maybe not directly relevant, but perhaps there's something else here.\n\nThe second context is about the 2009 pH1N1 pandemic in Hong Kong. It mentions research on convalescent plasma treatment and studies on the origins and pathogenesis of the virus. However, the 2009 pandemic is noted to have multiple waves? Wait, the user is asking about single-wave. The 2009 might not be single-wave. Also, the context here doesn't specify the number of waves for 2009, but other contexts might. Let me check others.\n\nThird context is about influenza virus circulation in Taiwan from 2008-2014, specifically the 2009 pH1N1 pandemic. It mentions using a Richards model variation for multi-wave epidemics, distinguishing between two types of turning points. So this is about multi-wave. Not helpful for single-wave.\n\nFourth context is an economic analysis of mitigation strategies for five pandemic severity categories based on the 2009 pandemic data. It references studies using simulation models and considers varying interventions. However, the 2009 pandemic itself\u2014was it a single wave? I think historically, the 2009 H1N1 pandemic had multiple waves, but the context here doesn't specify. The studies mentioned here are about modeling interventions, not the pandemic's wave structure.\n\nLooking back at the first context again, the 1889 pandemic had three waves. The 1918 pandemic had multiple waves too. The user is asking about severe, single-wave pandemics. The contexts provided don't mention any single-wave pandemics. The examples given (1889, 1918, 2009) all seem to have multiple waves. The research mentioned in the contexts is about multi-wave pandemics or models considering multiple",
      "retrieved_chunks": [
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies. 56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review. To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis.",
        ". The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic. Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave.",
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review. To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al. . The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic."
      ],
      "computed_relevance": 0.15384615384615385,
      "computed_utilization": 0.15384615384615385,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's try to figure out how many reported viral pneumonia cases there are based on the given context. The user is asking for the number of reported viral pneumonia cases. Let me look through the provided passages again.\n\nFirst, the first context is about the 2019-nCoV (which is now known as COVID-19) infected pneumonia. It mentions that as of January 26, 2020, there were 2744 confirmed cases. But the question is about viral pneumonia in general. However, the other contexts are about influenza viral pneumonia, specifically the 2009 H1N1 pandemic. \n\nLooking at the second context, it talks about bacterial co-infections in H1N1 cases. There's a mention of 77 fatal cases of pandemic H1N1v 2009 infection where 29% had bacterial pneumonia. But the question is about viral pneumonia, not bacterial. However, the term \"viral pneumonia\" here might refer to the primary infection caused by the virus. The passage says \"Primary influenza viral pneumonia,\" so maybe the 77 cases are of viral pneumonia caused by H1N1. But the exact number of viral pneumonia cases isn't directly stated here. The 77 is the number of fatal cases analyzed for co-infections.\n\nAnother part mentions attack rates during pandemics. For example, in La Gloria, the attack rate was 29% in adults and 61% in children. But attack rates are different from the number of cases. Attack rate is a percentage of the population affected, so without knowing the population size, we can't get an exact number from that.\n\nThe first context clearly states 2744 confirmed cases of 2019-nCoV infected pneumonia. Since 2019-nCoV is a coronavirus that causes viral pneumonia, those 2744 cases would be viral pneumonia. The other contexts are about influenza, but the question doesn't specify which virus. However, the user is asking for \"reported viral pneumonia,\" which could include both the 2019-nCoV and influenza cases. But the way the question is phrased might be looking for the number from the first context since it's explicitly about a specific virus. \n\nWait, the user's question is \"How many reported viral pneumonia?\" without specifying which virus. The first context gives",
      "retrieved_chunks": [
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths. A total of 51 cases have been cured and discharged. At present, 5794 suspected cases were recorded, 32,799 with close contacts to the confirmed patients have been tracked, 583 people were released from medical observation that day, and 30,453 people were still undergoing medical observation. A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients .",
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients . The most common coinfecting bacterial pathogens were pneumococcus, Staphylococcus aureus, and Streptococcus pyogenes, with a median duration of illness of 6 days . Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics.",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age . However, these rates may be different in geographic areas of low population density. Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01]."
      ],
      "computed_relevance": 0.06666666666666667,
      "computed_utilization": 0.06666666666666667,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage, it mentions that most analysis has been done using high throughput or \"deep\" sequencing methods for complete genome deduction. It also states that MERS-CoV was the first to have such widespread use of deep sequencing for studying an emerging viral outbreak. The technique allows for genomic coverage in a single experiment with repetitive measurements. \n\nOther passages talk about subgenomic sequencing being less published, but the main method mentioned is deep sequencing. There's also mention of whole genome sequencing being used extensively. However, the first passage specifically says \"most of the analysis... has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. \n\nI should make sure there's no conflicting information. Other parts mention subgenomic sequencing but note that it's been less often published during MERS-CoV studies. So the primary method is deep sequencing. The answer should reflect that.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods** for complete genome deduction. This approach allows for comprehensive genomic coverage in a single experiment with highly repetitious measurement of each nucleotide position. While subgenomic sequencing was traditionally a mainstay in viral outbreak studies, it has been less frequently utilized during MERS-CoV research compared to deep sequencing.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach. The technique can produce genomic . Earlier and subsequent versions of this chart are maintained on a personal blog length coverage in a single experiment with highly repetitious measurement of each nucleotide position . Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins .",
        "Global alignment of case definitions would further aid accurate calculation of a case fatality ratio by including subclinical case numbers. Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants. While human and camel whole genome sequences have retained >99 % identity with each other, members of genetically distinct lineages can and do swap genetic material when suitable conditions and coinfections co-occur . Shared identity implies that the major source for human acquisition is the DC, rather than another animal, although more testing of other animal species is needed to confirm that conclusion. Over a month, a DC",
        "Earlier and subsequent versions of this chart are maintained on a personal blog length coverage in a single experiment with highly repetitious measurement of each nucleotide position . Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable. Among all humans reported to be infected, nearly 40 % have died.",
        "The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable. Among all humans reported to be infected, nearly 40 % have died. Continued laboratory testing, sequencing, analysis, timely data sharing and clear communication are essential for such vigilance to be effective. Global alignment of case definitions would further aid accurate calculation of a case fatality ratio by including subclinical case numbers. Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants."
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look through the provided contexts to find the relevant methods mentioned.\n\nFirst, in the first context about Illuminating the Sites of Enterovirus Replication, they mention using a split-GFP-tagged viral protein. They also talk about transducing cells with MLV particles and using puromycin to select for GFP-expressing cells. Then they used immunofluorescence microscopy with a GFP antibody. But the question is about tracking the spread, so maybe that's part of it, but there's more in other contexts.\n\nLooking at the second context, Accelerated viral dynamics in bat cell lines, they used an inverted fluorescence microscope to monitor plates until GFP expression was seen. Then they imaged a subset of each well using a CellInsight CX5 platform with a 4X objective. They kept microscope settings standard, fixed exposure time, and imaged one color channel showing GFP cells in white. This seems like a method to track over time in cell cultures.\n\nThird context, Visualizing Viral Infection In Vivo... mentions using multi-photon intravital microscopy. They talk about expressing fluorescent proteins under certain promoters and using mouse lines with reporter genes like EGFP and mCherry. They mention long-term tracking without bleaching and good signal-to-noise ratio for small structures. This is in vivo imaging, so tracking in live animals.\n\nFourth context, Replication-Competent Influenza A Viruses... uses IVIS for whole-organ imaging ex vivo and flow cytometry to analyze infection progression in antigen-presenting cells. They observed GFP in lungs and tracked infection spread from airways to deeper areas. Also, they used flow cytometry to see percentages of infected cells like dendritic cells, macrophages, etc., at 48 hours post-infection.\n\nPutting this together, the methods used to track the spread include fluorescence microscopy (inverted and high-content screening platforms), multi-photon intravital microscopy for in vivo tracking, IVIS for whole-organ imaging, and flow cytometry for analyzing specific cell populations. Each method is used in different contexts\u2014some in cell cultures, others in live animals or ex vivo tissues. The answer should list these techniques as the methods used to track the spread.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using",
      "retrieved_chunks": [
        "Title: Illuminating the Sites of Enterovirus Replication in Living Cells by Using a Split-GFP-Tagged Viral Protein\nPassage: transduction, the MLV particles were 5 to 10 times concentrated using a 100-kDa concentrator . For the generation of single-cell clones stably expressing GFP, BGM and HeLa cells were transduced and grown in the presence of puromycin to generate pools of GFP-expressing cells, which were subsequently used to prepare single-cell clones by limiting dilution. Expression of GFP was monitored during passaging by immunofluorescence microscopy using the GFP antibody. Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed . From that time forward, a square subset of the center of each well was imaged periodically, using a CellInsight CX5 High Content Screening Platform with a 4X air objective .",
        "Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed . From that time forward, a square subset of the center of each well was imaged periodically, using a CellInsight CX5 High Content Screening Platform with a 4X air objective . Microscope settings were held standard across all trials, with exposure time fixed at 0.0006 s for each image. One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black . Title: Visualizing Viral Infection In Vivo by Multi-Photon Intravital Microscopy\nPassage: express cytoplasmic fluorescent proteins driven e.g., by the chicken \u03b2-actin promoter with cytomegalovirus enhancer or human ubiquitin C promoter .",
        "One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black . Title: Visualizing Viral Infection In Vivo by Multi-Photon Intravital Microscopy\nPassage: express cytoplasmic fluorescent proteins driven e.g., by the chicken \u03b2-actin promoter with cytomegalovirus enhancer or human ubiquitin C promoter . Many different mouse lines are available that contain reporter genes for cytoplasmic fluorescent proteins such as EGFP and mCherry . Due to strong and continuous expression rate of the fluorescent proteins long-term tracking of dividing cells without extensive bleaching is possible. In addition, with a superior signal-to-noise ratio visualization of small cellular structures with low cytoplasm content is feasible.",
        "Due to strong and continuous expression rate of the fluorescent proteins long-term tracking of dividing cells without extensive bleaching is possible. In addition, with a superior signal-to-noise ratio visualization of small cellular structures with low cytoplasm content is feasible. Although the approach to adoptively transfer fluorescent cells of interest into donor mice for functional imaging studies is fast and flexible,\n\nTitle: Replication-Competent Influenza A Viruses Expressing Reporter Genes\nPassage: lungs. Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs .",
        "Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs . The authors found that using a 10 6 PFU intranasal inoculation, 10% of dendritic cells were observed to express GFP and 2%-3% of macrophages and neutrophils were also GFP+ at 48 h post-infection ."
      ],
      "computed_relevance": 0.21739130434782608,
      "computed_utilization": 0.5652173913043478,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages with similar titles and mentions of CT disinfection procedures. \n\nFirst, I need to parse the context. The titles all mention emergency management related to COVID-19. The passages talk about noncontaminated CT disinfection procedures after examining a suspected case, fever-CT disinfection after examination, and preparing to disinfect imaging equipment immediately after.\n\nThe key points here are that after an examination involving a suspected or confirmed COVID-19 case, the CT scanner needs to be disinfected. The passages mention \"immediately after the examination\" and \"sterilization procedures.\" The term \"noncontaminated\" might be a bit confusing, but in the context of medical equipment, it likely refers to the process of making sure the equipment is free from contamination after use.\n\nSo, putting this together, the recommended procedure is to disinfect the CT scanner immediately after the examination. The answer should reflect that the equipment is disinfected right after use, possibly following specific sterilization steps. The context doesn't go into detailed steps, but the main takeaway is the timing and the necessity of the procedure post-examination.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment following the examination**. This includes adhering to established sterilization protocols to ensure the equipment is noncontaminated, as emphasized in the context. The process likely entails using appropriate disinfectants and following guidelines to prevent cross-contamination after examining suspected or confirmed COVID-19 cases.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}